Clinical features | A (n = 17) | B (n = 8) | C (n = 13) | D (n = 112) | E (n = 121) |
---|---|---|---|---|---|
Length of stay (days) | 10.5 ± 2.9* | 10.4 ± 4.9 | 9.0 ± 4.5 | 8.0 ± 2.9* | 9.1 ± 4.0 |
Fever | 17 (100.0%) | 8 (100.0%) | 12 (92.3%) | 100 (89.3%) | 106 (87.6%) |
Cough | 9 (52.9%) | 8 (100.0%) | 12 (92.3%) | 79 (70.5%) | 90 (74.4%) |
Rash | 4 (23.5%) | 4 (50.0%) | 0 (0.0%) | 23 (20.5%) | 19 (15.7%) |
Lymphadenopathy | 11 (64.7%)** | 6 (75.0%) | 5 (38.5%) | 41 (36.6%) | 35 (28.9%)* |
Pharyngitis | 16 (94.1%) | 7 (87.5%) | 10 (76.9%) | 89 (79.5%) | 87 (71.9%) |
Palatal petechiae | 9 (52.9%)** | 2 (25.0%) | 5 (38.5%) | 20 (17.9%)* | 24 (19.8%) |
Abnormal chest X ray | 8/9 (88.9%) | 2/2 (100.0%) | 3/5 (60.0%) | 50/57 (87.7%) | 53/65 (81.5%) |
Bronchitis (X ray) | 3/9 (33.3%) | 1/2 (50.0%) | 2/5 (40.0%) | 32/57 (56.1%) | 25/65 (38.5%) |
Pneumonia (X ray) | 5/9 (55.6%) | 1/2 (50.0%) | 1/5 (20.0%) | 18/57 (31.6%) | 28/65 (43.1%) |
Hepatomegaly | 5 (29.4%) | 2 (25.0%) | 3 (23.1%) | 7 (6.3%) | 11 (9.1%) |
Splenomegaly | 4 (23.5%) | 0 (0.0%) | 1 (7.7%) | 7 (6.3%) | 5 (4.1%) |
ALC >10% | 12/15 (80.0%)** | 0/6 (0.0%)* | 4/8 (50.0%) | 14/66 (21.2%)* | 18/77 (23.4%)* |
Elevated ESR | 8/14 (57.1%) | 5/6 (83.3%) | 2/10 (20.0%) | 43/81 (53.1%) | 31/66 (47.0%) |
Elevated CRP | 4/13 (30.8%) | 5/6 (83.3%) | 5/9 (55.6%) | 42/83 (50.6%) | 43/76 (56.6%) |
ALF | 9/13 (69.2%) | 1/4 (25.0%) | 2/6 (33.3%) | 9/36 (25.0%) | 15/38 (39.5%) |